Reversible cerebral vasoconstriction syndrome successfully treated by intrathecal nicardipine

Clin Neurol Neurosurg. 2021 Jul:206:106705. doi: 10.1016/j.clineuro.2021.106705. Epub 2021 May 20.

Abstract

Reversible cerebral vasoconstriction syndrome (RCVS) presents with a thunderclap headache, often prompting brain imaging. Most patients fully recover with supportive care and time, but oral calcium channel blockers are often used in patients with severe vasoconstriction. In this case report, we present a patient with severe vasoconstriction leading to weakness refractory to oral calcium channel blockers. Intrathecal nicardipine was administered via an external ventricular drain and the patient subsequently showed improvement of her weakness and significant improvement of vasospasm on Computed Tomography Angiography. We suggest further studies to determine the efficacy of intrathecal nicardipine in patients with RCVS not responsive to oral calcium channel blockers.

Keywords: Headache; Reversible Cerebral Vasoconstriction Syndrome; Vasospasm.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Female
  • Headache Disorders, Primary / etiology
  • Humans
  • Injections, Spinal
  • Nicardipine / administration & dosage*
  • Syndrome
  • Vasodilator Agents / administration & dosage*
  • Vasospasm, Intracranial / complications
  • Vasospasm, Intracranial / drug therapy*

Substances

  • Vasodilator Agents
  • Nicardipine